HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of the HOPE-2 study is to determine whether long term supplementation with folic acid, vitamins B6 and B12 aimed at homocyst(e)ine reduction reduces the rates of major fatal and nonfatal cardiovascular events in patients with established cardiovascular disease and/or diabetes mellitus.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 September 2005.

1 Dec 1999 31 Mar 2005 Unavailable 1 Oct 2005 1 Mar 2005 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


Not available